• LAST PRICE
    13.5998
  • TODAY'S CHANGE (%)
    Trending Up0.8098 (6.3315%)
  • Bid / Lots
    13.5500/ 7
  • Ask / Lots
    13.6000/ 7
  • Open / Previous Close
    12.7200 / 12.7900
  • Day Range
    Low 12.6500
    High 13.6000
  • 52 Week Range
    Low 12.6200
    High 32.5250
  • Volume
    262,688
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 12.79
TimeVolumeRCKT
09:32 ET1497212.75
09:33 ET1598312.7774
09:35 ET1262612.81
09:37 ET1889213.0081
09:39 ET20013.02
09:42 ET480013.185
09:44 ET802213.225
09:46 ET529913.345
09:48 ET30013.37
09:50 ET458613.3723
09:51 ET60013.3497
09:53 ET835813.4
09:55 ET452813.3798
09:57 ET48513.46
10:00 ET820813.4352
10:02 ET213313.35
10:04 ET608613.4499
10:06 ET324013.41
10:08 ET325413.405
10:09 ET420513.47
10:11 ET80013.43
10:13 ET90813.44
10:15 ET306913.475
10:18 ET170013.47
10:20 ET248713.47
10:22 ET250413.48
10:24 ET245013.44
10:26 ET632013.44
10:27 ET390613.41
10:29 ET290013.395
10:31 ET70013.37
10:33 ET2228013.28
10:36 ET70013.295
10:38 ET151813.29
10:40 ET133613.32
10:42 ET60013.385
10:44 ET20013.385
10:45 ET50013.42
10:47 ET30013.41
10:49 ET219113.43
10:51 ET50013.42
10:54 ET20013.42
10:56 ET437913.485
10:58 ET2012413.54
11:00 ET553113.5998
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRCKT
Rocket Pharmaceuticals Inc
1.2B
-4.9x
---
United StatesPHVS
Pharvaris NV
1.1B
-8.0x
---
United StatesELVN
Enliven Therapeutics Inc
1.2B
-13.6x
---
United StatesMESO
Mesoblast Ltd
1.1B
-11.6x
---
United StatesSPRY
ARS Pharmaceuticals Inc
1.3B
-26.8x
---
United StatesAPLT
Applied Therapeutics Inc
1.1B
-6.1x
---
As of 2024-11-22

Company Information

Rocket Pharmaceuticals, Inc. is a fully integrated, late-stage biotechnology company. The Company is advancing a sustainable pipeline of investigational genetic therapies designed to correct the root cause of complex and rare disorders. Its lentiviral (LV) vector-based gene therapies target hematologic diseases and consist of late-stage programs for Fanconi Anemia, a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer, Leukocyte Adhesion Deficiency-I (LAD-I), a severe pediatric genetic disorder that causes recurrent and life-threatening infections which are frequently fatal, and Pyruvate Kinase Deficiency (PKD), a monogenic red blood cell disorder resulting in increased red cell destruction and mild to life-threatening anemia. It also has two clinical stages and one pre-clinical stage in vivo adeno-associated virus (AAV) programs, including programs for Danon disease, Plakophilin-2 Arrhythmogenic Cardiomyopathy and BAG3 Dilated Cardiomyopathy.

Contact Information

Headquarters
9 Cedarbrook DriveCRANBURY, NJ, United States 08512
Phone
646-440-9100
Fax
781-676-2155

Executives

Chairman of the Board
Roderick Wong
President, Chief Operating Officer, Head of Research and Development
Kinnari Patel
Chief Executive Officer, Director
Gaurav Shah
Chief Financial Officer
Aaron Ondrey
Executive Vice President, Chief Technical Officer
Mayo Pujols

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.2B
Revenue (TTM)
$0.00
Shares Outstanding
91.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.01
EPS
$-2.75
Book Value
$5.46
P/E Ratio
-4.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.